Podcast

Pull Up a Chair with Dr. Freire: The COVID Conversations

Pull Up a Chair with Dr. FreireWelcome to the FNIH Podcast Series:
Pull Up a Chair with Dr. Freire: The COVID Conversations

Listen to the latest updates on progress in biomedical research from top experts in the field. This series features what you need to know in our ongoing effort to defeat the COVID-19 pandemic globally, including treatments, vaccines and next steps to regaining our footing in a healthier world.

In each episode, Dr. Maria Freire, President and Executive Director of the FNIH, interviews leading researchers and healthcare partners who are working tirelessly to defeat the COVID-19 pandemic. Tune in as guests share their unique and fascinating perspectives in finding solutions to stop the spread of this deadly virus.

 

 

EPISODE SIX: In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in surveillance of new COVID-19 variants. According to Dr. Schuchat, “It’s part of our national security to worry about these pathogens around the world, and nothing has illustrated this more clearly than COVID-19."

 

 

EPISODE FIVE: What is ACTIV and why is it so important to the public? Listen as Dr. Maria Freire, President and Executive Director of the FNIH, sits down with David Wholley, the FNIH's Senior Vice President of Research Partnerships, to tell the story of how the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership came together with urgency to address the COVID-19 crisis. Learn about how the FNIH guided the efforts of multiple U.S. government agencies, not-for-profit organizations and industry partners, all working together to develop COVID-19 vaccines and treatments.

 

 

EPISODE FOUR: Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future.

 

 

EPISODE THREE: Dr. Freire engages in a conversation with Dr. Francis Collins, NIH Director, around the incredible acceleration of biomedical research that was needed to get ahead of the COVID-19 crisis. They describe how the historic Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership convened government agencies, not-for-profit organizations and 20 pharmaceutical companies to research successful therapeutics and vet promising vaccines.

 

 

EPISODE TWO: Dr. Freire hosts an engaging and informative conversation with two scientists from Bristol Myers Squibb: Dr. Mary Beth Harler and Dr. Robert Plenge. Learn how treatments for COVID-19 are addressed along the continuum from initial work in the lab to patient care. Drs. Freire, Harler and Plenge also discuss the importance of looking at the biology of this virus to identify the best treatment options.

 

 

EPISODE ONE: Dr. Freire engages in a lively and eye-opening conversation with Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration. Drs. Freire and Woodcock explore the process to move drug candidates effectively and safely from clinical trials to market. Learn how it happened so quickly and what it means for you.